About Agena Bioscience
Agena Bioscience is a company based in San Diego (United States) founded in 2014 was acquired by Mesa Labs in September 2021. Agena Bioscience operates in a competitive market with competitors including DNAnexus, 908 Devices, Depixus, Genomics and Seven Bridges Genomics, among others.
Apps and channels of Agena Bioscience
its YouTube channel Agena Bioscience has 352 subscribers and 30 videos.
Videos from Agena Bioscience
The most watched videos on Agena Bioscience's YouTube channel, Agena Bioscience (352 subscribers). Click a video to play it here.
More on Agena Bioscience.
Funding Insights of Agena Bioscience
- Total Rounds 1
- Last Round Grant — $614,745
- First Round $614,745
(Jan 2018)
- Investors Count 1
All 1 funding rounds of Agena Bioscience with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jan 2018 | $614,745 | Grant | – | – |
2 investors in total: 2 institutional.
Investors in Agena Bioscience
Agena Bioscience has secured backing from 2 investors, including institutional investors. Prominent investors backing the company include Mesa Labs and European Union.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Government entites focused on freedom, democracy, equality and the rule of law, promoting peace and stability | 1958 | europa.eu | Brussels, Belgium | |
Measurement instruments and accessories for pharmacutical and medical industries | 1982 | mesalabs.com | Lakewood, United States |
Investor details for Agena Bioscience
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of Agena Bioscience
55 people are tracked at Agena Bioscience (11 in leadership, 4 in board & advisors, 40 in team).
| Name | Role | Group |
|---|---|---|
Pete Dansky | CEO | Leadership |
Aleksey Nakorchevsky | Director Software and Bioinformatics | Leadership |
Victoria Pratt | Director, Scientific Affairs for Pharmacogenetics | Leadership |
Glenn Wise | Director Quality And Regulatory | Leadership |
Darryl Irwin | VP, Scientific Affairs | Leadership |
晖 钟 | Sales Director,Greater China | Leadership |
Terance Kinninger | CFO | Leadership |
Alexandra Edery | Director of Finance and Accounting | Leadership |
Jason Kazmierczak | Director Of Sales, Americas | Leadership |
Rhett Affleck | VP Research and Development | Leadership |
Roman Niedbal | Vice President & Managing Director EMEA | Leadership |
Deval A. Lashkari | Director | Board & advisors |
Robert G. Shepler | Director | Board & advisors |
John Lillig | Executive Chairman | Board & advisors |
Paul Grossman | Director | Board & advisors |
Kristian Nyberg | Field Engineering Manager | Team |
Dinko Smajic | Field Service Engineer III | Team |
Romuald Contzler | Territory Business Manager - France and Distributor Channels | Team |
Cristian Mejia | Sales Development Representative | Team |
Patricia Kitala | Senior Territory Manager - Eastern Canada & North East US | Team |
35 more people are available in the full profile.
Complete people profiles for Agena Bioscience
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Timeline of Agena Bioscience
3 dated milestones of Agena Bioscience across 7 years, from founding to its latest funding, stage changes and deals.
- Founded Agena Bioscience is founded.
- Funding First funding round of $615K.
- Exit Acquired by Mesa Labs.
Competitors of Agena Bioscience
Agena Bioscience operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as DNAnexus, 908 Devices, Depixus, Genomics and Seven Bridges Genomics, among others.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| dnanexus.com | 2009 | Mountain View, United States | $472.55M | 143 | Cloud-based genome informatics and data management are provided. | |
| 908devices.com | 2012 | Boston, United States | $68.22M | 93 | Handheld chemical detection devices are manufactured using mass spectrometry. | |
| depixus.com | 2012 | Paris, France | $34.52M | – | Single-molecule genetic and epigenetic sequencing solutions are provided. | |
| genomics.com | 2014 | Oxford, United Kingdom | $115.54M | – | Genomic risk assessment and prevention platform is provided. | |
| sevenbridges.com | 2009 | Cambridge, United States | $113M | 112 | Cloud-based platform to analyze, store, and act on genomic data. | |
| hexagonbio.com | 2017 | Menlo Park, United States | $205.6M | 34 | Bioinformatics tools are provided for analyzing microbial genomic sequencing data. | |
| twinstrandbio.com | 2015 | Seattle, United States | $84.02M | 70 | DNA sequencing technology is developed to detect genomic mutations. | |
| bcplatforms.com | 1997 | Zurich, Switzerland | $47.15M | 8 | Platforms for genomic data analysis and management are provided. | |
| ingenuity.com | 1998 | Redwood, United States | $20.4M | 30 | Genomic data is analyzed and interpreted via web-based applications. |
Detailed competitors of Agena Bioscience
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of Agena Bioscience
The website of Agena Bioscience (agenabio.com) receives about 9.4K visits a month and ranks #2,232,177 among all websites worldwide, #3,041 in Biotechnology and Pharmaceuticals.
- Monthly visits9.4K
▲ 2.7% vs previous month
- Unique visitors3K
per month
- Global rank#2,232,177
among all websites
- Category rank#3,041
Health · Biotechnology and Pharmaceuticals
- Bounce rate34%
- Pages per visit2.9
- Average visit3 min 05 sec
- DevicesDesktop 67% · Mobile 33%
Websites whose visitors overlap most with Agena Bioscience. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
| lifesciencenord.de | 100% | 15.4K | #2,162,650 | View details | |
| bioagilytix.com | 94% | 41.6K | #919,146 | View details | |
| genomeweb.com | 50% | 116.4K | #371,609 | View details | |
tumedico.es | tumedico.es | 33% | – | #233,009 | – |
Latest news on Agena Bioscience
Complete news archive for Agena Bioscience
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Similar companies to Agena Bioscience
10 companies that operate in the same segment as Agena Bioscience (Genomics & Gene Therapy Platforms), ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
mRNA-based therapeutics for diseases including cancer and infections are developed. | 2010 | Cambridge, Massachusetts, United States | USD 2.78 B | USD 1.94 B | 5,800 | |
Digital sequencing technology for cancer detection is developed. | 2012 | Redwood City, California, United States | USD 557.5 M | USD 982.02 M | 2,020 | |
Circulating tumor DNA is screened for early cancer detection. | 2016 | Menlo Park, California, United States | USD 3.22 B | USD 147.17 M | 1,000 | |
Nanopore-based electronic systems for single-molecule analysis are developed. | 2005 | Oxford, Oxfordshire, United Kingdom | USD 1.3 B | USD 301.49 M | 1,480 | |
Provider of genetic test solutions to study ancestry, genealogy, and inherited traits | 2006 | Sunnyvale, California, United States | USD 943.53 M | USD 189.9 M | 265 | |
Provider of DNA testing services to create a family tree and ancestor | 2003 | Yehud, Central District, Israel | USD 40 M | – | – | |
Genetically modified cell lines are developed using AAV gene-editing platform. | 2007 | Cambridge, Cambridgeshire, United Kingdom | USD 46.29 M | – | – | |
Gene therapies for rare diseases including retinal dystrophies are developed. | 2013 | Philadelphia, Pennsylvania, United States | USD 82.8 M | USD 64.73 M | 822 | |
Therapeutics for genetic diseases are developed through targeted interventions. | 2015 | Palo Alto, California, United States | USD 434.2 M | USD 502.08 M | 730 | |
Provider of an online genealogy platform offering a host of services | 1996 | Lehi, Utah, United States | USD 146.2 M | – | – |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Agena Bioscience
Agena Bioscience was founded in 2014 and raised its 1st funding round 4 years after it was founded.
Agena Bioscience is headquartered in San Diego, United States. It is registered at San Diego, California, United States.
Pete Dansky is the current CEO of Agena Bioscience.
Agena Bioscience offers mass spectrometry-based platform, the MassARRAY System for highly multiplexed, nucleic acid detection,iPLEX, chemistry for genotyping, copy number variation, and somatic mutation profiling; UltraSEEK chemistry for rare mutation detection and others. The company also provides services for Genotyping, Somatic mutation profiling, DNA methylation analysis, and Quantitative gene expression and copy number variant analysis.
Agena Bioscience's top competitors include DNAnexus, 908 Devices and Depixus.
Agena Bioscience has 2 investors. Key investors include Mesa Labs, and European Union.
Yes. Agena Bioscience was acquired by Mesa Labs in September 2021.